Search Login Register

Insulin-Like Growth Factor I (IGF-1) Summary

Description: A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor.

Also Known As: IGF-1; Somatomedin C; IGF-I-SmC; Insulin Like Growth Factor I; Insulin-Like Somatomedin Peptide I Show All >>

Networked: 9913 relevant articles (463 outcomes, 1573 trials/studies) for this Bio-Agent

Key Diseases for which Insulin-Like Growth Factor I is Relevant

  1. Acromegaly : 95 outcomes 87 studies in 718 results
  2. Neoplasms (Cancer) : 41 outcomes 166 studies in 1299 results
  3. Body Weight (Weight, Body) : 34 outcomes 42 studies in 654 results
  4. Insulin Resistance : 21 outcomes 46 studies in 341 results
  5. Wounds and Injuries (Trauma) : 11 outcomes 30 studies in 171 results
Show All >>

Drugs Related to Insulin-Like Growth Factor I

  1. Insulin-Like Growth Factor I (IGF-1)
  2. Insulin (Novolin)
  3. Growth Hormone (Somatotropin)
  4. Insulin-Like Growth Factor Binding Protein 3
  5. Glucose (Dextrose)
  6. Somatostatin (Somatotropin Release-Inhibiting Factor)
  7. pegvisomant
  8. Insulin-Like Growth Factor II (Somatomedin A)
  9. Messenger RNA (mRNA)
  10. Octreotide (Sandostatin)
Show All >>

Therapies Related to Insulin-Like Growth Factor I

  1. Drug Therapy (Chemotherapy)
  2. Radiotherapy
  3. Injections
  4. Aftercare (After-Treatment)
  5. Transplantation (Transplant Recipients)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.